COMPANY

Plakous Therapeutics

Also known as PLAKOUS THERAPEUTICS, INC. · 2 sources

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $827K (SBIR Phase II 5R44HD100243-06, continuation, notice Jun 9, 2026). NIH RePORTER 5R44HD100243-06 (Jun 9, 2026)
Evidence (1 event)
- Jun 9, 2026 · NIH RePORTER 5R44HD100243-06
  Organization: PLAKOUS THERAPEUTICS, INC.; City/State: PFAFFTOWN, NC; Project number: 5R44HD100243-06; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-09; FY total cost (award amount): 826522; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 9, 2026 Grant Government grant — SBIR: $826,522 (annual award, as published), announced Jun 9, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Jun 12, 2025 Grant Government grant — SBIR: $976,322 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Last 2 years.

Jun 9, 2026 Government grant — SBIR: $826,522 (annual award, as published), announced Jun 9, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Jun 12, 2025 Government grant — SBIR: $976,322 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NICHD. Source: government award database. source ↗